trending Market Intelligence /marketintelligence/en/news-insights/trending/2yzaq2t9yd_vntdoqyktta2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Avid Bioservices CFO resigns

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Avid Bioservices CFO resigns

Paul Lytle is voluntarily resigning as CFO of Avid Bioservices Inc.

Lytle's resignation will be effective 90 days from the date of his Feb. 23 notice.

The company is starting a search for its next CFO.

Avid Bioservices is a Tustin, Calif.-based a biopharmaceutical company that researches and develops antibodies for the treatment of cancer in the U.S.